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BACTEREMIA AFTER LIVER TRANSPLANTATION; 
FEW ISSUES IN SELECTION OF ANTIBIOTICS 
FOR TREATMENT AND PROPHYLAXIS 
S. Kusne, M. Alessiani, M. Martin, 
J. Fungi T.E. Starzl 
Infections after liver transplantation are still 
associated with significant morbidity and mortality. 
Bacterial infections account for up to 50% of such 
events according to various series. The majority of 
these infections are nosocomial and many of them are 
associated with technical surgical problems. Bacteremia 
represents "invasive" infection and knowing the common 
agents involved helps in selection of antibiotics for 
treatment and prophylaxis. Successful use of antibiotics 
requires familiarity with their characteristics, 
potent.ial side effects and interactions with other 
medications. 
COMMON BACTEREMIAS 
In a previous study from our institution, we had a 
frequency of bacteremia of 26%, occurring after liver 
transplantation in 101 consecutive patients (1). All 33 
bacterial isolates in that study are shown in table 1. 
Fifty one percent of episodes of bacteremia with a 
single isolate were due to gram negative enteric 
organisms, and only 27% to gram positive isolates. This 
is in contrast to what has been publ ished by other 
centers that routinely use selective bowel 
decontamination in liver transplantation. In one study 
81% of bacteremias were caused by gram positive 
organisms and only 6% by gram negatives (2). Anaerobes 
account for a very small portion of bacterial infections 
after liver transplantation in any center. This 
information is important for selection of emp1r1c 
antibiotics in the septic patient. Empiric antibiotic 
coverage depends on the suspected source for bacteremia. 
For example, if cholangitis is suspected coverage should 
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include gram negative enteric organisms and enterococci; 
if intravascular lines or wound infection is suspected 
staphylococcus coverage should be considered. 
The most common source of bacteremia after liver 
transplantation is the abdomen and this is often related 
to surgical/or mechanical problems (surgical wounds, 
hepatic artery thrombosis and other vascular 
complications, biliary obstruction and leaks etc). Most 
bacteremias occur during the first two months after 
transplantation (primary or retransplantation), and in 
our original study 61% of thirty three bacteremias 
followed this rule. 
SELECTION OF ANTIBIOTICS FOR PROPHYLAXIS 
Perioperative antibiotic coverage for liver 
transplantation should include gram negative organisms 
and enterococci. In our institution we use cefotaxime or 
ceftizox in combination with ampicillin for the duration 
of 72 hours. Trimethoprim/sulfamethoxazole given for 
prevention of pneumocystis carinii pneumonia may also 
have an effect on prevention of bacterial infections. 
The routine use of selective bowel decontamination is 
practiced by some centers. The literature does not show 
clearly that there is an advantage to its use since: 
a. although infections caused by gram negative bacteria 
are low those caused by gram positive bacteria are 
higher, b. there is no difference in overall mortality 
and Intensive Care unit stay, c. the emergence of 
resistant organisms is a possibility (3). 
OTHER FACTORS IMPORTANT IN SELECTION OF ANTIBIOTICS 
Cholangitis 
It accounts for 6-10% of bacterial infections after 
transplantation and is associated with bacteremia in 
about 40%. Diagnosis is usually difficult due to the 
fact that biliary draining tubes (like T-tube) are often 
colonized with bacteria, inflammatory white cells are 
not easily recognized in bile and the latter is not 
always available for culture. Therefore empiric 
antibiotics should be started whenever there is clinical 
suspicion of bacterial cholangitis. The clinician should 
be familiar with the fact that some antibiotics do not 
penetrate well in bile (4). For example Imipenem/ 
Cilastatin has a very broad antibacterial coverage but 
penetrates bile very poorly, if at all. Cholangitis is 
usually associated with biliary obstruction which imply 
no penetration of antibiotics to bile, until obstruction 
is relieved. Some authors feel that serum concentration 
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of antibiotics is as important as biliary penetration. 
Although the most common antibiotics used in cholangitis 
are ampicillin or cephalosporins in combination with 
aminoglycoside, the ureido-penicillins (like 
mezlocillin, azlocillin and piperacillin) with or 
wi thout aminoglycosides may have very important role 
because of their good biliary penetration. 
Hepatotoxicity 
Antibacterial agents prescribed after liver 
transplantation may be toxic to the new allograft. 
Medications prescribed for treatment and prevention of 
tuberculosis (like isoniazid, pyrazinamide and rifampin) 
may cause hepatitis. Hypersensitivity reactions with 
liver enzymes elevation can be seen with erythromycin 
and sulfonamides. SGOT elevation at times self limited 
can be seen with use of commonly prescribed antibiotics 
(like carbenicillin, Cloxacillin, moxalactam etc.). 
Bleeding 
Some beta-lactam antibiotics may affect coagulation 
and cause bleeding. One mechanism which causes 
hypoprothrombinemia is probably through interference 
with vitamin k metabolism (5). This is described with 
cephalosporins that have Methyl-thio-tetrazole side 
chain (like cefamandole, moxalactam and cefoperazone) . 
A second mechanism results in platelets dysfunction and 
is described with antibiotics like ticarcillin, 
piperacillin and mezlocillin. This is important to 
remember since these patients may have coagulation 
abnormalities secondary to liver disease. 
Nephrotoxicity 
The aminoglycosides are the main antibiotics to 
cause nephrotoxicity after liver transplantation. They 
usually damage the proximal tubules causing non-oliguric 
renal failure. This is more pronounced when an 
aminoglycoside is prescribed together with vancomycin. 
Some authors feel that there is increased risk of renal 
dysfunction due to interaction of liver disease and the 
aminoglycosides (6). Obviously when the clinician can 
choose non nephrotoxic antibiotic it is preferable, but 
in some infections (like enterococcus sepsis) there is 
no "other choice". 
Interaction with other drugs 
Before prescribing any antibiotics or anti-
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microbials in patients after transplantation one has 
finally to consider possible interactions with other 
medications. The interactions of Cyclosporin (Cya) with 
antimicrobials were summarized by others (7). Through 
inhibition or induction of hepatic P-450 enzyme system 
some agents can increase and others can lower Cya 
levels. Erythromycin and ketoconazole can increase Cya 
level causing nephrotoxicity while rifampin can 
significantly lower Cya level leading to rejection of 
the allograft. 
TABLE 1: All 33 bacteremia isolates that 
occurred in 101 consecutive liver 
transplant patients. 
BACTERIA INVOLVED (No; %) NUMBER EPISODES 
Gram Negative Bacteremia (17; 51) 
Pseudomonas aeruginosa 
Escherichia coli 
Klebsiella pneumoniae 
citrobacter freundii 
Enterobacter cloacae 
Gram Neg./Pos. Bacteremia (4; 12) 
Gram positive Bacteremia (9; 27) 
Enterococcus 
Staphylococcus epidermidis 
Staphylococcus au reus 
Streptococcus bovis 
Listeria monocytogenes 
Anaerobic Bacteremia (3; 9) 
Bacteroides fragilis 
Clostridia species 
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